{
    "2018-12-17": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报:政策多发扰动期,建议关注品牌中药的配置价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策",
                        "扰动期",
                        "品牌中药",
                        "配置价值"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}